Medicinal chemistry – Page 65
-
Business
Novartis in the spotlight in mis-selling investigations
Crackdown on pharma marketing continues with US and Japanese cases
-
PodcastConotoxins
Helen Scales finds out how unique toxins found in deadly cone snail stings could herald the next generation of painkillers
-
OpinionIs there a drug for that?
Derek Lowe ponders whether anything is truly ‘undruggable’ if we look in the right places
-
NewsFlu drug stockpile may be worthless
UK committee asks government to think again on Tamiflu as its effectiveness in a pandemic is in doubt
-
OpinionThe morning after the night before
Replacing alcohol with a more benign drug sounds like a great idea, but it faces insurmountable hurdles, says Mark Peplow
-
OpinionPut the chemistry back in medicinal chemistry
Pursuing skewed priorities and easy options has impoverished the pharmaceutical industry, says David Lathbury.
-
OpinionRolling boulders uphill
Is Derek Lowe troubled by his failure to develop a compound that has made it to the pharmacy shelf?
-
Business
Regulator cracks down on 23andMe
Personal genetic profiler ordered to stop selling DNA test kits
-
PodcastPotassium bromide
Did chemistry help control tension in the trenches? Brian Clegg investigates potassium bromide
-
Business
Novartis sells off blood diagnostics division
$1.7bn deal reinforces firm’s focus on core pharmaceuticals
-
News
Rough patch for India’s clinical trial industry
Bad publicity has added to the woes of an industry worried by regulatory uncertainty
-
-
OpinionNatural born chemists
Redesigning nature’s catalysts is tantalising but tricky, says Derek Lowe
-
News
Supreme court ruling brings clinical trials to a halt in India
Pressure from campaign group precipitates action that puts 162 drug trials on ice
-
BusinessGSK to apply for malaria vaccine approval
Infection protection drops over time, but the firm will go ahead with regulatory submission
-
Business
Japan confirms Novartis clinical trial data fabrication
Investigation into blood pressure blockbuster continues
-
FeatureSeek and destroy
Nanoparticles that can find specific targets before delivering a drug could change medicine. Akshat Rathi investigates
-
FeatureGiving screening the green light
Chemists are working with toxicologists at an earlier stage to avoid problems further down the chain, as Emma Davies reports
-
FeatureRe-arming the antibiotic arsenal
How can we make new antibiotics? Phillip Broadwith takes a look
-
CareersNon-profit pharma
Not-for-profit drug discovery is growing into a promising niche employment opportunity within the pharmaceutical industry. James Mitchell Crow investigates